Halozyme Therapeutics saw the highest growth of 3.99% in patent filings in April and 0.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 3.99% and grants by 0.59%. GlobalData’s DataBook provides a comprehensive analysis of Halozyme Therapeutics‘s patent filings and grants. Buy the databook here.
Halozyme Therapeutics has been focused on protecting inventions in United States(US) with six publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 31% filings and 22% grants. The United States(US), Japan(JP), European Patent Office(EPO), and Denmark(DK) patent Office are among the top ten patent offices where Halozyme Therapeutics is filings its patents. Among the top granted patent authorities, Halozyme Therapeutics has 22% of its grants in United States(US), 22% in Spain(ES) and 11% in European Patent Office(EPO).
Roche could be the strongest competitor for Halozyme Therapeutics
Patents related to climate change and addiction lead Halozyme Therapeutics's portfolio
Halozyme Therapeutics has the highest number of patents in climate change followed by, addiction and rare diseases. For climate change, nearly 29% of patents were filed and 50% of patents were granted in Q2 2024.
Drug delivery devices related patents lead Halozyme Therapeutics portfolio followed by hospital supplies, and hepatitis a
Halozyme Therapeutics has highest number of patents in drug delivery devices followed by hospital supplies, hepatitis a, pertussis (whooping cough), and tetanus. For drug delivery devices, nearly 2% of patents were filed and 2% of patents were granted in Q2 2024.
For comprehensive analysis of Halozyme Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.